GYRE
Gyre Therapeutics Inc.
NASDAQ: GYRE · HEALTHCARE · BIOTECHNOLOGY
$7.68
+4.49% today
Updated 2026-04-30
Market cap
$696.73M
P/E ratio
381.50
P/S ratio
5.98x
EPS (TTM)
$0.02
Dividend yield
—
52W range
$7 – $12
Volume
0.1M
Gyre Therapeutics Inc. (GYRE) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |